Studies were conducted to determine the effects of sublethal, acute, total-body irradiation (600 R) on the immune response of mice to a replicating antigen. Irradiation was performed at varying times (O to 21 days) prior to immunization with attenuated Venezuelan equine encephalomyelitis virus, TC-83. Development of protective immunity was studied by inoculating subgroups of irradiated mice with virulent Venezuelan equine encephalomyelitis virus on days 1 through 28 after immunization. Irradiation failed to affect the overt clinical response of mice inoculated with the attenuated strain, but antibody responses and the onset of protective immunity was delayed, particularly in mice irradiated 2 h to 3 days prior to vaccination. Immunity afforded by TC-83 developed more rapidly as the interval between irradiation and vaccination increased: when this interval was 14 or more days, the temporal course of immune response in irradiated mice was similar to that of nonirradiated vaccinees. Persistence of TC-83 viremia was greatly prolonged in irradiated mice throughout the irradiation recovery period and probably provided the antigenic stimulus responsible for delayed development of effective immunity.
The immunosuppressive effect of X irradiation has been studied extensively (10, 24, 29, 30) , particularly with regard to development of circulating antibody against soluble or nonreplicating particulate antigens. In a few studies, living bacterial or viral antigens of low virulence were employed (11, 16) , but the altered pattern of disease rather than the immune response in the irradiated host was characterized. Moreover, although the importance of the time of irradiation with respect to immunization has been widely recognized (8-10, 15, 16, 24, 29, 30, 33) , few studies have been reported in which irradiation has preceded antigen injection by more than a few days (8, 15, 24, 33) .
The interaction of radiation effects and host responses to vaccines prepared from attenuated microorganisms is of particular interest. Certainly the enhanced susceptibility of irradiated animals to infection with nonpathogenic organisms is well documented (3, 16, 20, 21) , and it is recognized that attenuation of a virulent strain is only relative; i.e., virulence may be reduced for a selected animal species or age group. For example, an attenuated Venezuelan equine encephalomyelitis (VEE) virus, TC-83, derived by 83 effective for immunization of healthy human subjects (1, 17) and Equidae (27, 28) , is likewise avirulent for 21-day-old mice but lethal for suckling mice and will kill 5 to 20% of hamsters regardless of age (22, 35) . Furthermore, immunosuppression with cyclophosphamide renders hamsters uniformly susceptible to lethal infection with this virus (12) , suggesting that TC-83 could serve as a model to investigate the effects of radiation on host response to a living, attenuated antigen. The present study was designed to examine the safety and efficacy of TC-83 vaccination in mice at various intervals after sublethal irradiation. 
RESULTS
To determine lethality of TC-83 vaccination for irradiation-stressed animals, mice were irradiated when 30 days old at various times prior to vaccination with TC-83 and observed for signs of illness and death. Composite results from six experiments are shown in Table 1 . Injection of sublethally irradiated mice with 5,000 MIPID50 of TC-83 failed to produce observable clinical disease that could be associated with the virus or to increase mortality significantly regardless of time of injection. Histopathology of tissues obtained daily from 1 to 7 days after TC-83 vaccination of a -3-day irradiated group was similar to that of the corresponding irradiated, nonvaccinated controls.
The absence of evidence of TC-83-induced disease in irradiated mice allowed examination of the effects of irradiation on VEE HI antibody production and on protection against virulent virus. Thirty-day-old mice were exposed to 600 R, vaccinated with TC-83, and subsequently challenged i.c. with VE-1 virus. Results compiled from eight experiments are summarized in Table 2 . Mice in both the irradiated and nonirradiated groups failed to survive a challenge administered within 3 days of immunization. As the interval between vaccination and challenge was prolonged, incidence of survival of nonirradiated control mice increased progressively from 3 of 17 mice in the 4-day group to 70 of 77 tween persistence of viremia and delayed onset of protection was noted.
The HI response of irradiated, vaccinated mice ( Fig. 1) (Table 4) ; some mice were resistant on day 1 and most were protected by day 3. In contrast, few mice were resistant to i.c. challenge by day 4, and 7 days were required before all were protected.
Except for the difference due to i.c. versus i.p. challenge, the response of adult mice to virulent virus challenge after irradiation and vaccina- (Table 5) . Again, as the time interval between irradiation and vaccination was decreased, the delay in onset of protection increased. Mice irradiated either 14 or 21 days before immunization were similar to nonirradiated, vaccinated control mice, in that partial resistance to i.p. VE-1 challenge developed as early as day 1 after vaccination. Essentially all nonirradiated and 21-day-irradiated adult mice were resistant to challenge within 3 days, whereas 14-day-irradiated mice were resistant to challenge within 5 days; immunity developed more slowly in mice that were irradiated 0 to 8 days before vaccination.
DISCUSSION From the viewpoint of disease prophylaxis, it is important to know when a vaccine can be administered safely to an irradiated subject, what degree of protection will ensue, and if onset of protection will be delayed. The present study was designed to examine these questions with a live, replicating antigen.
For most viral infections there is marked variation in susceptibility of different hosts. The many variables that influence the pathogenesis of experimental virus infections in a host (19) undoubtedly also play an important role in TC-83 virus infections, as suggested by differences in lethality for hamsters, suckling mice, and weanling mice (22, 35) . Although many studies indicate that immune suppression is associated with increased morbidity and mortality to virus infections (19) , our findings indicate that radiation does not potentiate TC-83 infection in mice. These observations are not compatible with the enhanced lethality reported for hamsters immunosuppressed with cyclophosphamide (12) . Studies by other investigators on the temporal relationship between antigen injection and X-ray exposure and its effect on immune response indicate that antibody response is depressed when injection of a nonviable antigen follows or immediately precedes X irradiation (7-10, 15, 24, 30, 33) . The degree of depression increases as the interval between injection and irradiation decreases, and complete inhibition of antibody response often occurs. In the present study with a living antigen, immune response was dependent upon viral multiplication and was evaluated by determining protection of the host against virulent virus as well as by development of antibody response. Although irradiation delayed the onset of protection afforded by the attenuated VEE vaccine in both 30-day-old and adult mice, the degree of protection ultimately obtained was unaltered. With both age groups of mice, it was apparent that as the interval between irradiation and vaccine injection decreased, the time required to develop protection increased.
The early protection (1 to 3 days postvaccination) against i.p. challenge that was induced in nonirradiated mice by TC-83 vaccination has been previously reported for hamsters (6) . Similar early development of nonspecific protection was observed in studies with inactivated vaccines (4); this heteroprotection against other viruses was attributed to viral interference and/or induction of interferon. Although no attempt was made in these studies to measure interferon or to check for heterologous protection, both TC-83 and VE-1 virus induce and are inhibited by interferon (13) . Consequently, it is possible that the marked reduction in early protection of adult mice irradiated 0 to 8 days before vaccination reflected modification in the ability of host cells to activate induction and/or release of interferon. Such an interpretation would be in agreement with the report of Jullien and DeMaeyer, which indicated that interferon induction by Sindbis virus is suppressed when total-body radiation is applied 1 to 8 days before virus inoculation (14) .
The time lapsed after irradiation when comparable levels of protection occurred is essentially the same whether vaccination is given soon after irradiation or vaccination is delayed for 7 or 14 days postirradiation. For example ( 11, 1975 on October 24, 2017 by guest http://iai.asm.org/ Downloaded from are obtained in the -7-day vaccinated group when challenged at 7 and 14 days postvaccination, which are 14 and 21 days postirradiation, respectively. This finding that protection appeared as soon after irradiation if vaccination is performed on or about the time of irradiation, or if it is delayed until some degree of radiation recovery had occurred, was somewhat unexpected because studies by other investigators with nonviable antigens and a comparable radiation dose indicated maximal depression (31, 32) to complete inhibition of antibody response (10, 24) . However, the finding that TC-83 viremia was prolonged suggests that replication of the living antigen (TC-83) may allow it to persist until immunocompetence is restored, whereas a nonviable antigen might be processed and/or cleared before immune mechanisms are restored. If a nonviable antigen such as alumprecipitated toxoid could persist until recovery from irradiation takes place, then a delayed antibody response could occur with a nonviable antigen, as suggested by Silverman and Chin (25) .
Prolongation of viremia in irradiated mice is consistent with the findings with other viruses (34) . Prolongation of viremia in irradiated mice might well occur if antibody production is inhibited or suppressed (26) and if interferon production (14) is inhibited. Data regarding HI antibody and resistance to challenge support this opinion because the most prolonged viremia occurred in mice from groups that demonstrated the lowest levels of HI antibody or protection. Further, as the time interval between irradiation and vaccination increases, HI antibody titers increase, and viremia, although still protracted over vaccine controls, shows less prolongation.
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